Vemics
Nanuet
About Vemics
Vemics, Inc. builds portal-based, virtual work and learning environments primarily in healthcare and related industries that enable individuals and organizations to communicate, collaborate, work, and learn at a distance as if everyone were in the same office or room. The company's hosted solutions eliminate the need for companies, medical practices, and individuals in the United States to buy, integrate, or maintain collaborative technologies and provide a single point of access for online communication, collaboration, and learning. Its products and services include iMedicor, a collaborative online portal designed for and by medical professionals to facilitate practice productivity and secure exchange of education, information, and ideas in real-time; iMedicor Integration Driver, an integrated software that allows an iMedicor user to communicate and transmit records and images across EMR system; and iMedicor ClearLobby, a pharmaceutical company-marketing platform that would allow physicians to communicate directly with their pharmaceutical company certified sales representatives electronically. Vemics, Inc. also offers iMedicor LiveAccess, a collaboration platform that delivers video, wideband audio, and a suite of Web’collaboration tools in a single browser window accessible from PCs or laptops enabling organizations and individuals to work and learn virtually; iMedicor NuScribe, a voice-recognition driven document creation and management system that enables physicians to create and manage patient medical records online using voice recognition technology; and iMedicor CME Education Solutions, a service that delivers an educational experience for physicians, administrators, nurses, and other healthcare workers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: vemics.com
- Phone: 888-810-7706
Canonical: https://fsome.com/organization/vemics-3048501 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.